To determine whether differences exist in the location of necrotizing enterocolitis (NEC) in infants with congenital heart disease (CHD) versus those without CHD. STUDY DESIGN: Retrospective cohort study utilizing 11 years of patient data. Inclusion criterion was surgical exploration for NEC. Presence or absence of CHD was determined. Surgical and/or pathology reports were reviewed to identify the location of NEC. Data were analyzed by t-tests and w 2 analyses. RESULT: One hundred and sixty-seven patients met the inclusion criteria. CHD infants had a higher percentage of mortality. There was no difference in the location of NEC between non-CHD and CHD patients, with the predominant location being the small intestine in both. In addition, there was no difference in the location of NEC between preterm non-CHD patients and full-term CHD patients with the small intestine again being the primary site. CONCLUSION: Despite differences in gestational age between non-CHD and CHD patients, the location of NEC in these infants did not differ.
INTRODUCTION
Infants with congenital heart disease (CHD) are at increased risk for developing necrotizing enterocolitis (NEC). The incidence of NEC in infants with CHD has been reported to be 3.3-11% 1-3 , which is 10-100 Â higher than rates reported for the entire late preterm/term newborn population. 1, 4, 5 Of striking difference is the higher mortality associated with NEC among infants with CHD versus those without CHD. 5 The pathophysiology of NEC among infants with CHD is largely unknown, although an alteration in intestinal blood flow remains a leading theory. It may be beneficial, therefore, to recognize which areas of the intestine are most typically affected by alterations in blood flow, thus better guiding prevention and management of this disease process. 2, 6, 7 Previous reports of NEC in non-CHD patients have documented principally small intestinal involvement in preterm infants (o37 weeks) versus primarily colonic involvement in full-term infants (437 weeks). [8] [9] [10] It has therefore been assumed that the predominant location of NEC in infants with CHD is colonic, as most of these infants are born at or near term. However, the prevalent location of NEC in patients with CHD has not previously been investigated.
The goal of this study was to determine if differences exist in the location of NEC in infants with CHD versus those without CHD.
METHODS
This study was approved by our institutional review board. A retrospective chart review was performed on all patients p6 months of age, who underwent exploratory laparotomy from January 2000 to December 2011 at Nationwide Children's Hospital. Indication for surgical exploration was identified using ICD-9 codes and chart information, and patients with confirmed or suspected NEC were included in this study. Patients were excluded from this study if they underwent surgery for indications other than NEC. Echocardiograms, if performed, were reviewed. Patients were then divided into two groups: non-CHD group, which included any patient with normal cardiac anatomy including a patent foramen ovale and/or a patent ductus arteriosus, and CHD group, which included all other infants with a defined CHD that would require an intervention.
Baseline demographics collected included gestational age and birth weight. Age at surgical procedure and subsequent mortality were documented. Surgical or pathology reports were reviewed for all infants to identify the location of NEC as well as confirm the presence of the disease. Location of NEC was divided into five groups: small intestine, large intestine, ileocecal, NEC totalis and mixed segments.
Infants with NEC and CHD were compared with those infants with NEC but no CHD. t-tests were used to examine statistically significant differences in the means of continuous variables, and R Â C w 2 tests were used to examine associations between categorical variables. Stata SE 12 (StataCorp LP, College Station, TX, USA) was used for all analyses and Po0.05, two-tailed, was considered significant.
RESULTS
A total of 511 infants underwent exploratory laparotomy at our institution from January 2000 through December 2011. One hundred and sixty-five patients met inclusion criteria (147 non-CHD and 18 CHD). CHD diagnoses are presented in Table 1 . Non-CHD patients had a significantly lower gestational age, birth weight and mortality, and were significantly older at the time of surgery versus the CHD patients (Table 2 ).
There were no significant differences in the location of NEC between the non-CHD and CHD patients, with the predominant location being isolated to the small intestine in both groups (31% versus 33%, P ¼ NS) (Table 3) . However, because the CHD population had an average gestational age of 34 weeks, which was more premature than expected, a subgroup analysis was performed to determine if NEC location differed between preterm and term infants. Patients were separated into two groups, premature infants without CHD (n ¼ 137) and term infants with CHD (n ¼ 9). These groups were then compared with respect to the location of NEC. There was again no significant difference in the location of NEC between the preterm non-CHD patients and the term CHD patients, with isolated small intestine again being the primary site of involvement (34% versus 44%, P ¼ NS) ( Table 4) .
DISCUSSION
NEC is a significant cause of morbidity and mortality in infants born prematurely as well as in neonates with CHD. Previous studies have documented the small intestine to be the predominant location of NEC in premature infants, whereas the large intestine is the main affected area in term infants. 9, 11 As most neonates with CHD are born at term, our hypothesis was that the large intestine was also the most affected site in this population, but no study has been performed to verify this assumption. However, this retrospective review demonstrated no difference in the predominant location of NEC in infants without CHD compared with those with CHD. Furthermore, the small intestine remained the predominant location of NEC when comparing preterm infants without CHD versus term infants with CHD.
These findings in a heterogeneous CHD population are similar to that reported by Hebra et al. 7 , in which they found 40% (10/25) of infants with hypoplastic left heart syndrome had documented NEC isolated to the small intestine. This coincides with findings reported previously for the preterm population. Yeh et al 9 found that in a cohort of 80 preterm infants with NEC, 34 of whom required surgical management, the terminal ileum was the predominant location of insult. Another study of 13 preterm infants, identified a higher number of infants with isolated ileal involvement compared with small bowel and colonic involvement or colonic involvement alone. 12 Although these studies involved small sample sizes, were observational in design, and did not directly compare NEC in preterm infants with term CHD infants, the similar findings reinforce this study's observations of no significant difference in the location of NEC between these two groups. This may suggest that the pathophysiology of NEC in infants with CHD may not be as different as previously thought, compared with that of the preterm infant population.
The main risk factors for NEC in premature infants appear to be intestinal immaturity that then predisposes to decreased barrier protection and colonization of bacteria that is not part of the normal mature intestinal flora. 4, 13, 14 The latter factor may be due to multiple intrinsic and extrinsic causes. In contrast, risk factors for NEC in term infants are multiple and include, but are not limited to, CHD, intrauterine growth restriction, birth asphyxia, polycythemia, exchange transfusion, hypoglycemia, sepsis, chorioamnionitis and gestational diabetes. 4, 11, 13 However, the exact etiology for the increased risk for NEC in CHD infants has not been definitively elucidated. Infants with CHD share many risk factors common to the preterm population that may predispose them to NEC. These include antibiotic use, chronic central line placement, respiratory distress and hypotension/shock. Indeed, shock/hypotension has been shown to be a risk factor for NEC in this population; 2, 6, 7 however, the alteration of systemic blood flow may not be the sole factor involved in the development of NEC in CHD infants. A study conducted by Leung et al. 2 found that the Abbreviation: CHD, congenital heart disease. P-values were determined by two-tailed t-tests for gestational age, birth weight and age at surgery. P-value for mortality was calculated using w 2 analysis. Abbreviations: CHD, congenital heart disease; NEC, necrotizing enterocolitis. Abbreviations: CHD, congenital heart disease; NEC, necrotizing enterocolitis.
Intestinal location of necrotizing enterocolitis in CHD C Cozzi et al majority of variables suspected of causing intestinal hypoperfusion in infants with CHD did not significantly correlate to their development of NEC. 2 Animal models have shown that chronic hypoxia has a negative impact on overall somatic growth as well as a negative effect on the growth of the liver and kidneys. 15, 16 One animal study demonstrated that although chronic hypoxia did not affect small intestinal growth, specific enzyme activities were decreased compared with controls. 17 Immature brain development and metabolism have been well documented in fetuses and neonates with CHD. 15, 18, 19 These data suggest that there may be a component of intestinal immaturity in infants with CHD. 8 If fullterm infants with CHD have immature gut development mirroring that of premature infants, this potentially similar pathophysiology may explain the similarities in the location of NEC between the two groups in this study. Unfortunately, the current clinical outcomes of infants with CHD are not analogous to preterm infants, as can be demonstrated by the significantly higher rate of mortality in the CHD infants in this study as well as others. 5, 8 However, some clinical aspects, such as NEC location may be more comparable than previously thought.
There are several limitations to this study. This is a retrospective study with all the inherent limitations of such a study design. The overall number of patients evaluated was relatively small, though larger than most previous studies. Only infants that underwent surgery were included, so a large population of infants with medical NEC was not reviewed. However, because of this method of analysis, there was gross and pathologic identification of NEC location, versus reliance on radiographic evaluation for estimating NEC location. Finally, the infants with CHD were a heterogeneous population, but all had significant cardiac disease that required or would have required intervention.
In conclusion, this study found that despite baseline differences in demographics, the location of NEC in infants with CHD did not differ from that in preterm infants. Given this, we suggest that the pathophysiology of NEC in infants with CHD may not be as different from the preterm population as once previously assumed. Future studies are needed to assess if other clinical similarities exist between CHD infants and preterm infants that develop NEC. This may aid in preventative and treatment options for both these high-risk groups.
